Johnson & Johnson
About J&J
Johnson & Johnson, together with its subsidiaries, engages in the research, development, manufacture and sale of healthcare products worldwide.
The company operates through two primary segments.
The Innovative Medicine segment offers prescription products across various therapeutic areas, including:
-
Immunology: Rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis
-
Infectious Diseases: HIV/AIDS
-
Neuroscience: Mood disorders, neurodegenerative disorders, and schizophrenia
-
Oncology: Prostate cancer, hematologic malignancies, lung cancer, and bladder cancer
-
Cardiovascular and Metabolism: Thrombosis, diabetes, and macular degeneration
-
Pulmonary Hypertension: Pulmonary arterial hypertension
The MedTech segment includes a wide range of medical technologies and devices:
-
Electrophysiology products for heart rhythm disorders
-
Heart recovery solutions for severe coronary artery disease and cardiogenic shock
-
Circulatory restoration devices for coronary and peripheral artery diseases
-
Neurovascular care for hemorrhagic and ischemic stroke
-
Orthopaedics portfolio, including products and technologies for hips, knees, trauma, spine, and sports medicine
-
Surgical technologies for advanced and general procedures, breast aesthetics, and reconstruction
-
Vision care products, including ACUVUE contact lenses and TECNIS intraocular lenses for cataract surgery
The company distributes its products through wholesalers, hospitals, and retailers, as well as to physicians, nurses, clinics and eye care professionals.
Johnson & Johnson was founded in 1886 and is headquartered in New Brunswick, New Jersey.
J&J's Business Strategy
Johnson & Johnson (J&J) has strategically transformed into a focused healthcare company, concentrating on two primary segments: Innovative Medicine and MedTech. This shift was marked by the spin-off of its consumer health division, Kenvue, in 2023, allowing J&J to dedicate resources to high-growth, high-innovation markets.…
Available on Finplify
Free account required
Our Take on J&J
Pros:
✅ Diversified Healthcare Conglomerate: J&J operates across three major segments: pharmaceuticals, medtech (medical devices), and consumer health (now separated under the Kenvue spin-off). This diversification provides a strong balance of growth, defensiveness, and cash flow stability.
✅ Leading Pharmaceutical Portfolio: J&J’s pharma division includes major…
Available on Finplify
Free account required
Company Details
Key Metrics
Fundamental Analysis
Proprietary 5-category scoring system
Score Fingerprint
Section Scores
Full Breakdown & Peer Ranking
See the detailed score for every metric and how this stock ranks against its sector peers
Unlock the full research on J&J
Get the full fundamental score breakdown, business strategy, our investment take, live charts and AI-powered briefings. All in one ad-free workspace.
300+ Curated Stocks
A hand-picked universe of world-class businesses across every major market and sector.
AI Analyst Briefings
Deploy your own AI analyst that monitors your portfolio and delivers daily intelligence reports.
Proprietary Fundamentals
Five-category scoring for every stock — profitability, liquidity, leverage, cash flow, and valuation.